DE506574T1 - Protein mit Cytokinaktivität, dafür kodierende rekombinante DNS, transformierte Zellen und Mikroorganismen. - Google Patents

Protein mit Cytokinaktivität, dafür kodierende rekombinante DNS, transformierte Zellen und Mikroorganismen.

Info

Publication number
DE506574T1
DE506574T1 DE0506574T DE92400858T DE506574T1 DE 506574 T1 DE506574 T1 DE 506574T1 DE 0506574 T DE0506574 T DE 0506574T DE 92400858 T DE92400858 T DE 92400858T DE 506574 T1 DE506574 T1 DE 506574T1
Authority
DE
Germany
Prior art keywords
protein
microorganisms
recombinant dna
transformed cells
cytokine activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE0506574T
Other languages
English (en)
Inventor
Daniel Caput
Pascual Ferrara
Guillemot
Mourad Kaghad
Bouteiller Christine Labit-Le
En Saint-Pierre Leplatois
Marilyn Magazin
Adrian Minty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elf Sanofi SA
Original Assignee
Elf Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9103904A external-priority patent/FR2674537B1/fr
Priority claimed from FR9200137A external-priority patent/FR2685919B1/fr
Application filed by Elf Sanofi SA filed Critical Elf Sanofi SA
Publication of DE506574T1 publication Critical patent/DE506574T1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5446—IL-16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5437—IL-13
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four
DE0506574T 1991-03-29 1992-03-27 Protein mit Cytokinaktivität, dafür kodierende rekombinante DNS, transformierte Zellen und Mikroorganismen. Pending DE506574T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9103904A FR2674537B1 (fr) 1991-03-29 1991-03-29 Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules animales transformees.
FR9200137A FR2685919B1 (fr) 1992-01-08 1992-01-08 Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules animales transformees.

Publications (1)

Publication Number Publication Date
DE506574T1 true DE506574T1 (de) 1994-11-17

Family

ID=26228598

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69206301T Expired - Lifetime DE69206301T2 (de) 1991-03-29 1992-03-27 Protein mit der Aktivität vom Typ von Cytokin, dafür kodierende rekombinante DNS, transformierte Zellen und Mikroorganismen.
DE0506574T Pending DE506574T1 (de) 1991-03-29 1992-03-27 Protein mit Cytokinaktivität, dafür kodierende rekombinante DNS, transformierte Zellen und Mikroorganismen.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69206301T Expired - Lifetime DE69206301T2 (de) 1991-03-29 1992-03-27 Protein mit der Aktivität vom Typ von Cytokin, dafür kodierende rekombinante DNS, transformierte Zellen und Mikroorganismen.

Country Status (14)

Country Link
US (1) US5652123A (de)
EP (1) EP0506574B1 (de)
JP (1) JP2865423B2 (de)
AT (1) ATE130869T1 (de)
CA (1) CA2083826C (de)
DE (2) DE69206301T2 (de)
DK (1) DK0506574T3 (de)
ES (1) ES2054601T3 (de)
GR (2) GR940300052T1 (de)
HK (1) HK1007435A1 (de)
HU (2) HU217099B (de)
IE (1) IE72165B1 (de)
MD (1) MD1652G2 (de)
WO (1) WO1992017586A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5596072A (en) * 1992-08-21 1997-01-21 Schering Corporation Method of refolding human IL-13
JPH07508179A (ja) * 1992-08-21 1995-09-14 シェリング・コーポレーション ヒトインターロイキン−１３
US6274711B1 (en) 1993-06-14 2001-08-14 Inserm, Institut National De La Sante Et De La Recherche Medicale Purified mammalian CTLA-8 antigens and related reagents
BR9607403A (pt) * 1995-02-10 1998-07-07 Novo Nordisk As Protease cultura biologicamente pura isolada processos de preparação de uma protease e de lavagem uso de uma protease composição detergente aditivo de detergente
DE69635514T2 (de) * 1995-02-10 2006-08-10 Novozymes A/S Bacillus-proteasen
US6576232B1 (en) * 1998-04-03 2003-06-10 The Penn State Research Foundation IL13 mutants
JP5519087B2 (ja) 1998-12-14 2014-06-11 ジェネティクス インスティテュート，エルエルシー サイトカインレセプター鎖
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
US6703360B2 (en) 2000-04-07 2004-03-09 Heska Corporation Compositions and methods related to canine IgG and canine IL-13 receptors
US20070104710A1 (en) * 2002-06-28 2007-05-10 Domants Limited Ligand that has binding specificity for IL-4 and/or IL-13
US20110223168A1 (en) * 2002-12-27 2011-09-15 Greg Winter Ligand that has binding specificity for il-4 and/or il-13
US20050059024A1 (en) * 2003-07-25 2005-03-17 Ambion, Inc. Methods and compositions for isolating small RNA molecules
KR20130041373A (ko) * 2003-12-23 2013-04-24 제넨테크, 인크. 신규 항-ｉｌ１３ 항체 및 그 용도
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
US20090098142A1 (en) * 2004-06-09 2009-04-16 Kasaian Marion T Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
AU2005307831A1 (en) 2004-11-17 2006-05-26 Amgen, Inc. Fully human monoclonal antibodies to IL-13
WO2006124451A2 (en) * 2005-05-11 2006-11-23 Centocor, Inc. Anti-il-13 antibodies, compositions, methods and uses
BRPI0616359B8 (pt) 2005-09-30 2022-08-30 Medimmune Ltd Composição farmacêutica, processo para purificação de um anticorpo de il-13 e uso de uma composição farmacêutica contendo um anticorpo
MY188368A (en) 2006-09-08 2021-12-06 Abbott Lab Interleukin-13 binding proteins
AR066240A1 (es) * 2007-04-23 2009-08-05 Wyeth Corp Metodos y composiciones para tratar y monitorear el tratamiento de trastornos asociados con il-13
MX2011001909A (es) 2008-08-20 2011-03-21 Centocor Ortho Biotech Inc Anticuerpos anti-interleucina-13 modificados, composiciones, metodos y usos.
GB0904214D0 (en) 2009-03-11 2009-04-22 Ucb Pharma Sa Biological products
FR2957799B1 (fr) 2010-03-26 2012-08-17 Inst Des Vaisseaux Et Du Sang Compositions proangiogeniques, leur procede de preparation et leurs utilisations
JP6546178B2 (ja) 2013-09-13 2019-07-17 ジェネンテック， インコーポレイテッド 細胞株中の宿主細胞タンパク質及び組換えポリペプチド産物を検出及び定量化するための組成物並びに方法
SG11201601823TA (en) 2013-09-13 2016-04-28 Genentech Inc Methods and compositions comprising purified recombinant polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92685A0 (en) * 1988-12-16 1990-09-17 Us Commerce Dna encoding lymphokine/cytokine like proteins,cells transformed thereby and production of said proteins and antibodies against them

Also Published As

Publication number Publication date
IE921016A1 (en) 1992-10-07
US5652123A (en) 1997-07-29
IE72165B1 (en) 1997-03-26
HU217099B (hu) 1999-11-29
EP0506574B1 (de) 1995-11-29
HU9203753D0 (en) 1993-03-29
CA2083826A1 (en) 1992-09-30
HK1007435A1 (en) 1999-04-09
CA2083826C (en) 1999-04-27
MD1652G2 (ro) 2001-12-31
MD1652F2 (en) 2001-04-30
EP0506574A1 (de) 1992-09-30
DK0506574T3 (da) 1996-04-09
ES2054601T3 (es) 1996-04-01
ATE130869T1 (de) 1995-12-15
DE69206301T2 (de) 1996-06-13
JPH06500567A (ja) 1994-01-20
HUT68162A (en) 1995-05-29
ES2054601T1 (es) 1994-08-16
WO1992017586A1 (fr) 1992-10-15
DE69206301D1 (de) 1996-01-11
MD970099A (en) 1998-04-30
GR3019043T3 (en) 1996-05-31
GR940300052T1 (en) 1994-08-31
JP2865423B2 (ja) 1999-03-08

Similar Documents

Publication Publication Date Title
DE506574T1 (de) Protein mit Cytokinaktivität, dafür kodierende rekombinante DNS, transformierte Zellen und Mikroorganismen.
AU7587696A (en) Differentiation-suppressive polypeptide
DE60033138D1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
ATE414775T1 (de) Polypeptide mit prolyldipeptidylaminopeptidase- aktivität und dafür kodierende nukleinsäuren
UA84666C2 (ru) ВЫДеЛЕНнЫЙ ПОЛИНУКЛЕОТИД, КОДИРУЮЩИЙ СЛИТОЙ ПРОТЕИН С ПЕСТИЦИДНОЙ АКТИВНОСТЬЮ, И ТРАНСГЕННАЯ КЛЕТКА-ХОЗЯИН
NO177570C (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
AU2002307510A1 (en) Cytokine protein family
AU1384995A (en) Human circulating cytokine cc-1
ATE203272T1 (de) Rekombinant dns kodierend für eine endochitinase
DK0427863T3 (da) DNA, som koder for protein, som kan kombinere med forstærker for alfa-fetoprotein-gen
DE69735039D1 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
RU97103147A (ru) Днк-последовательности, кодирующие человеческие протеины тх и ту, родственные конвергирующему интерлейкин-1-бета ферменту
ES2012283A6 (es) Procedimiento de obtencion de una proteina de endotoxina de efecto insecticida.
NZ505350A (en) DNA encoding a tumour antigen peptide (43 kDa) for diagnosis or treatment of tumours
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
AU5964398A (en) Novel mouse cxc chemokine receptor
MXPA04000397A (es) Polipeptidos que tienen actividad catalitica de isomerasa de carotenoides, acidos nucleicos que los codifican y usos de los mismos.
ATE241698T1 (de) Hst-2 mutein, dafür kodierende dns und herstellung
AU654155B2 (en) A DNA encoding a protein which binds to the enhancer of alpha-fetoprotein gene
EP1295943A4 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
WO2003099995A3 (en) Murine ortholog of the human disrupted-in-schizophrenia 1 gene
ATE71656T1 (de) Fuer kolonie stimulierenden faktor kodierende dns, dadurch kodiertes peptid, diese dns enthaltende vektoren und transformierte wirte und herstellung derselben.
WO1999060117A3 (fr) Polypeptide prax-1
EP0953642A4 (de) Antigenprotein aus infektiöse laryngotracheitis viren